Amanote Research
Register
Sign In
The Costs of Oral Versus Intravenous Chemotherapy in Insured, Low Income Patients With Breast or Colon Cancer
Value in Health
- United Kingdom
doi 10.1016/j.jval.2013.03.648
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2013
Authors
V. Noxon
J. Wu
Publisher
Elsevier BV
Related search
Oral vs. Intravenous Empirical Antimicrobial Therapy in Febrile Neutropenic Patients Receiving Childhood Cancer Chemotherapy
Jornal de Pediatria
Child Health
Pediatrics
Perinatology
Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine
Clinical Colorectal Cancer
Oncology
Gastroenterology
HD Chemotherapy in the Treatment of Poor Prognostic or Advansed Stage Breast Cancer Patients
Bone Marrow Transplantation
Transplantation
Hematology
Intravenous Iron Versus Oral Iron Versus No Iron With or Without Erythropoiesis- Stimulating Agents (ESA) for Cancer Patients With Anaemia: A Systematic Review and Network Meta-Analysis
Cochrane Database of Systematic Reviews
The Safety and Efficacy of Intra-Arterial Versus Intravenous Neoadjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer: A Meta-Analysis
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
Preference of Elderly Patients’ to Oral or Intravenous Chemotherapy in Heavily Pre-Treated Recurrent Ovarian Cancer: Final Results of a Prospective Multicenter Trial
Gynecologic Oncology Research and Practice
Validity of Self-Reports of Breast Cancer Treatment in Low-Income, Medically Underserved Women With Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy
Journal of Pain and Symptom Management
Neurology
Anesthesiology
Pain Medicine
Nursing
Resource Utilization and Cost Saving Analysis of Subcutaneous Versus Intravenous Trastuzumab in Early Breast Cancer Patients
Oncotarget
Oncology
